Protalix BioTherapeutics (PLX) Profit After Tax (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 432.79% |
| Dec 31, 2025 | -333.72% |
| Sep 30, 2025 | 1,335.98% |
| Jun 30, 2025 | 104.53% |
| Mar 31, 2025 | -155.73% |
| Dec 31, 2024 | 100.68% |
| Sep 30, 2024 | 246.89% |
| Jun 30, 2024 | 52.06% |
| Mar 31, 2024 | 23.97% |
| Dec 31, 2023 | -226.35% |
| Sep 30, 2023 | -109.58% |
| Jun 30, 2023 | 717.66% |
| Mar 31, 2023 | 16.28% |
| Dec 31, 2022 | -4.85% |
| Sep 30, 2022 | 33.13% |
| Jun 30, 2022 | -133.33% |
| Mar 31, 2022 | 65.71% |
| Dec 31, 2021 | -58.78% |
| Sep 30, 2021 | 62.65% |
| Jun 30, 2021 | -91.79% |
| Mar 31, 2021 | -1,943.08% |
| Dec 31, 2020 | 106.98% |
| Sep 30, 2020 | -8.76% |
| Jun 30, 2020 | -386.07% |
| Mar 31, 2020 | 403.09% |
| Dec 31, 2019 | 108.17% |
| Sep 30, 2019 | 54.02% |
| Jun 30, 2019 | -6.59% |
| Mar 31, 2019 | -33.68% |
| Dec 31, 2018 | -2.10% |
| Sep 30, 2018 | 37.11% |
| Jun 30, 2018 | -16.89% |
| Mar 31, 2018 | 45.59% |
| Dec 31, 2017 | -16.33% |
| Sep 30, 2017 | -2,641.56% |
| Jun 30, 2017 | 100.76% |
| Mar 31, 2017 | -2,329.08% |
| Dec 31, 2016 | 66.60% |
| Sep 30, 2016 | 32.83% |
| Jun 30, 2016 | -26.23% |
| Mar 31, 2016 | 30.77% |
| Dec 31, 2015 | -225.10% |
| Sep 30, 2015 | 38.22% |
| Jun 30, 2015 | 5.07% |
| Mar 31, 2014 | 58.81% |
| Dec 31, 2013 | -210.28% |
| Sep 30, 2013 | 15.94% |
| Jun 30, 2013 | -58.23% |
| Mar 31, 2013 | 56.25% |
| Dec 31, 2012 | -80.27% |
| Sep 30, 2012 | -156.82% |
| Jun 30, 2012 | 263.31% |
| Mar 31, 2012 | 33.76% |
| Dec 31, 2011 | -0.43% |
| Sep 30, 2011 | 35.17% |
| Jun 30, 2011 | -170.96% |
| Mar 31, 2011 | 40.76% |
| Dec 31, 2010 | -244.70% |
| Sep 30, 2010 | 75.36% |